KOCAA
Knights of Columbus Asset Advisors Portfolio holdings
AUM
$1.65B
1-Year Return
26.62%
This Quarter Return
-2.98%
1 Year Return
+26.62%
3 Year Return
+114.99%
5 Year Return
+224.68%
10 Year Return
–
AUM
$980M
AUM Growth
-$21.7M
(-2.2%)
Cap. Flow
+$24.9M
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
22.92%
Holding
339
New
21
Increased
142
Reduced
133
Closed
25
Top Buys
| 1 |
Emerson Electric
EMR
|
$4.81M |
| 2 |
Hershey
HSY
|
$4.69M |
| 3 |
Apple
AAPL
|
$4.11M |
| 4 |
Tesla
TSLA
|
$3.38M |
| 5 |
Microsoft
MSFT
|
$3.28M |
Top Sells
| 1 |
Colgate-Palmolive
CL
|
$6.11M |
| 2 |
Oshkosh
OSK
|
$4.65M |
| 3 |
ManpowerGroup
MAN
|
$4.3M |
| 4 |
Lam Research
LRCX
|
$4.06M |
| 5 |
ConocoPhillips
COP
|
$2.95M |
Sector Composition
| 1 | Technology | 19.38% |
| 2 | Financials | 15.11% |
| 3 | Healthcare | 13.29% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
226
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $769K | 0.08% |
41,074
-92
| -0.2% | -$1.72K |
|
227
Amazon
AMZN
$2.48T
| $765K | 0.08% |
6,769
-1,025
| -13% | -$116K |
|
228
LoveSac
LOVE
$297M
| $705K | 0.07% |
34,598
+4,073
| +13% | +$83K |
|
229
Coca-Cola
KO
$292B
| $689K | 0.07% |
12,308
+1,278
| +12% | +$71.5K |
|
230
Castle Biosciences
CSTL
$683M
| $680K | 0.07% |
26,064
+3,201
| +14% | +$83.5K |
|
231
Johnson & Johnson
JNJ
$430B
| $667K | 0.07% |
4,085
-749
| -15% | -$122K |
|
232
Fate Therapeutics
FATE
$116M
| $654K | 0.07% |
29,178
+3,533
| +14% | +$79.2K |
|
233
Lantheus
LNTH
$3.72B
| $622K | 0.06% |
+8,851
| New | +$622K |
|
234
Match Group
MTCH
$9.18B
| $614K | 0.06% |
12,857
| – | – |
|
235
Thermo Fisher Scientific
TMO
$186B
| $591K | 0.06% |
1,166
-76
| -6% | -$38.5K |
|
236
Deckers Outdoor
DECK
$17.9B
| $590K | 0.06% |
11,328
-534
| -5% | -$27.8K |
|
237
Verizon
VZ
$187B
| $586K | 0.06% |
15,431
-696
| -4% | -$26.4K |
|
238
Fox Class B
FOX
$24.9B
| $564K | 0.06% |
19,793
-1,193
| -6% | -$34K |
|
239
TSMC
TSM
$1.26T
| $557K | 0.06% |
8,130
+119
| +1% | +$8.15K |
|
|
ITCI
240
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $535K | 0.05% |
11,490
+1,367
| +14% | +$63.7K |
|
241
Gilead Sciences
GILD
$143B
| $492K | 0.05% |
7,968
-354
| -4% | -$21.9K |
|
242
Oracle
ORCL
$654B
| $490K | 0.05% |
8,023
-257
| -3% | -$15.7K |
|
243
MetLife
MET
$52.9B
| $481K | 0.05% |
7,914
-527
| -6% | -$32K |
|
244
Fiserv
FI
$73.4B
| $443K | 0.05% |
+4,738
| New | +$443K |
|
245
Revolve Group
RVLV
$1.7B
| $431K | 0.04% |
19,879
-20,640
| -51% | -$447K |
|
246
Magnite
MGNI
$3.54B
| $415K | 0.04% |
63,165
-65,841
| -51% | -$433K |
|
247
Infosys
INFY
$67.9B
| $414K | 0.04% |
24,371
+117
| +0.5% | +$1.99K |
|
248
Merck
MRK
$212B
| $403K | 0.04% |
4,684
-288
| -6% | -$24.8K |
|
249
Franklin Resources
BEN
$13B
| $394K | 0.04% |
18,300
-891
| -5% | -$19.2K |
|
250
Northrop Grumman
NOC
$83.2B
| $390K | 0.04% |
829
-305
| -27% | -$143K |
|